...
首页> 外文期刊>Chemistry: A European journal >A uniform sub-50nm-sized magnetic/upconversion fluorescent bimodal imaging agent capable of generating singlet oxygen by using a 980nm laser
【24h】

A uniform sub-50nm-sized magnetic/upconversion fluorescent bimodal imaging agent capable of generating singlet oxygen by using a 980nm laser

机译:能够通过使用980nm激光产生单线态氧的均匀的50nm以下磁性/上转换荧光双峰成像剂

获取原文
获取原文并翻译 | 示例

摘要

Upconverting nanoparticles (UCNPs) with fascinating properties hold great potential as nanotransducers for solving the problems that traditional photodynamic therapy (PDT) has been facing. In this report, by using well-selected bifunctional gadolinium (Gd)-ion-doped UCNPs and water-soluble methylene blue (MB) combined with the water-in-oil reverse microemulsion technique, we have succeeded in developing a new kind of UCNP/MB-based PDT drug, NaYF _4:Er/Yb/Gd@SiO _2(MB), with a particle diameter less than 50nm. Great efforts have been made to investigate the drug-formation mechanism and provide detailed physical and photochemical characterizations and the potential structure optimization of the as-designed PDT drug. We envision that such a PDT drug will become a potential theranostic nanomedicine for future near-infrared laser-triggered photodynamic therapy and simultaneous magnetic/optical bimodal imaging.
机译:具有引人入胜特性的上转换纳米颗粒(UCNP)作为解决传统光动力疗法(PDT)所面临问题的纳米传感器具有巨大潜力。在本报告中,通过使用精选的双功能ado离子(Gd)掺杂的UCNP和水溶性亚甲基蓝(MB)结合油包水反向微乳液技术,我们成功开发了一种新型的UCNP / MB基PDT药物,NaYF _4:Er / Yb / Gd @ SiO _2(MB),粒径小于50nm。已经进行了巨大的努力来研究药物形成机理,并提供了详细的物理和光化学特性以及所设计的PDT药物的潜在结构优化。我们预想,这种PDT药物将成为未来近红外激光触发的光动力疗法和同步磁/光双峰成像的潜在治疗学纳米药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号